Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds (Q35950558)

11 August 2017

Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds (English)

1 reference

11 August 2017

Angela L Gibson

1

1 reference

11 August 2017

Christina L Thomas-Virnig

2

1 reference

11 August 2017

John M Centanni

3

1 reference

11 August 2017

Sandy J Schlosser

4

1 reference

11 August 2017

Colette E Johnston

5

1 reference

11 August 2017

Kelly F Van Winkle

6

1 reference

11 August 2017

Andrea Szilagyi

7

1 reference

11 August 2017

Li-Ke He

8

1 reference

11 August 2017

Ravi Shankar

9

1 reference

11 August 2017

B Lynn Allen-Hoffmann

10

1 reference

11 August 2017

1 May 2012

1 reference

Wound Repair and Regeneration

11 August 2017

1 reference

11 August 2017

20

1 reference

11 August 2017

3

1 reference

11 August 2017

414-424

1 reference

StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Chimeric composite skin substitutes for delivery of autologous keratinocytes to promote tissue regeneration.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Host defense peptides for use as potential therapeutics.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Comparison of therapeutic antibiotic treatments on tissue-engineered human skin substitutes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Gene therapy progress and prospects: the skin--easily accessible, but still far away

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Wound healing: an overview

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Antimicrobial peptides: therapeutic potential

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Bacteria and wound healing.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Calcium triggers beta-defensin (hBD-2 and hBD-3) and chemokine macrophage inflammatory protein-3 alpha (MIP-3alpha/CCL20) expression in monolayers of activated human keratinocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Antimicrobial characterization of human beta-defensin 3 derivatives

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

The clinical relevance of microbiology in acute and chronic wounds

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

The 10(5) bacterial growth guideline: reassessing its clinical relevance in wound healing.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Wound pathophysiology, infection and therapeutic options

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

An in vivo comparison of topical agents on wound repair

2 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00786.X

Activity of histone H1.2 in infected burn wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00786.X

Expression of human beta-defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00786.X

Real-time monitoring of antimicrobial activity with the multiparameter microplate assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00786.X

The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00786.X

Protegrin-1 enhances bacterial killing in thermally injured skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00786.X

Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00786.X

Use of continuous electrical capacitance and transepidermal water loss measurements for assessing barrier function in neonatal rat skin.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349450

Human beta-defensin-3 promotes wound healing in infected diabetic wounds

24 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-475X.2012.00786.X

A mouse model of burn wounding and sepsis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22564233

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1524-475X.2012.00786.X

1 reference

11 August 2017

1 reference

11 August 2017

1 reference